Clinical Trial Update: A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures [Phase 2]

View source ↗

Summary

This document describes a Phase 2 dose-escalation trial of levetiracetam for neonatal seizures that is currently ongoing. The study is recruiting and targets co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxic-ischemic Encephalopathy
• Neonatal Encephalopathy
• Neonatal Seizures

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: University of California, San Diego | Conditions: Neonatal Seizure, Neonatal Encephalopathy | Phase 2 | Status: RECRUITING